[Federal Register Volume 89, Number 194 (Monday, October 7, 2024)]
[Notices]
[Pages 81087-81088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22948]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Request for Information (RFI): To Inform the Development of the 
2026-2030 National HIV/AIDS Strategy and the National Strategic Plans 
for Sexually Transmitted Infections, Vaccines, and Viral Hepatitis

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Through this Request for Information (RFI), the Office of 
Infectious Disease and HIV/AIDS Policy (OIDP) in the Office of the 
Assistant Secretary for Health (OASH) in the Office of the Secretary, 
Department of Health and Human Services (HHS), invites feedback from 
Federal, State, Tribal, territorial, and local governments; community-
based organizations and faith-based organizations; Urban Indian 
Organizations; health plans and payers; health care providers, and 
other health-related and social services

[[Page 81088]]

organizations; private-sector entities; researchers and academic 
institutions; people living with and who experience risk for disease; 
and other interested constituents on Strategic Plans to serve as 
national roadmaps to guide efforts to address HIV, sexually transmitted 
infections (STI), and viral hepatitis, and to improve and enhance the 
development and use of vaccines in the United States.

DATES: To be assured consideration, comments must be received at the 
addresses provided below, no later than 5:00 p.m. ET on December 6, 
2024.

ADDRESSES: Submissions must be submitted electronically via the 
following website: https://app.smartsheetgov.com/b/form/68aa1bd9c54b42829f99e85cc4ab1e82.

FOR FURTHER INFORMATION CONTACT: Questions about this RFI should be 
directed to Nathan Fecik; Phone: 202-795-7616; Email: 
<a href="/cdn-cgi/l/email-protection#4b1832252f2e262228380b232338652c243d"><span class="__cf_email__" data-cfemail="ca99b3a4aeafa7a3a9b98aa2a2b9e4ada5bc">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: OIDP requests feedback on the development of 
the following (collectively referred to as the Strategic Plans):

<bullet> National HIV/AIDS Strategy for the United States: 2026-2030 
(NHAS)
<bullet> Sexually Transmitted Infections National Strategic Plan for 
the United States: 2026-2030 (STI Plan)
<bullet> Vaccines National Strategic Plan for the United States: 2026-
2030 (Vaccines Plan)
<bullet> Viral Hepatitis National Strategic Plan for the United States 
2026-2030 (Viral Hepatitis Plan)

    The National HIV/AIDS Strategy for the United States: 2022-2025 
(https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf), the Sexually 
Transmitted Infections National Strategic Plan for the United States: 
2021-2025 (https://www.hhs.gov/sites/default/files/STI-National-Strategic-Plan-2021-2025.pdf), the Vaccines National Strategic Plan: 
2021-2025 (https://www.hhs.gov/sites/default/files/HHS-Vaccines-Report.pdf), and the Viral Hepatitis National Strategic Plan for the 
United States: A Roadmap to Elimination: 2021-2025 (https://www.hhs.gov/sites/default/files/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf) expire at the end of calendar year 2025.
    OIDP, in collaboration with the White House Office of National AIDS 
Policy (focused specifically on the NHAS) and Federal partners, is 
leading work to develop the next iteration of these interrelated 
Strategic Plans through 2030. As the next NHAS will be developed in 
parallel with the three national strategic plans, OIDP is collecting 
information for the 2026-2030 National HIV/AIDS Strategy at the request 
of the White House Office of National AIDS Policy. OIDP invites 
community input as people have served as the cornerstone for developing 
the Strategic Plans since their inception.
    Background: The Strategic Plans serve as national roadmaps for a 
broad range of constituents to help prevent, diagnose, treat, and cure 
disease, improve health outcomes, reduce health disparities and 
inequities, and advance research and technology. The plans include a 
common vision, overarching goals, objectives, and strategies, and 
indicators to measure national progress toward established targets.
    The development of the next iteration of the Strategic Plans will 
serve as an opportunity to incorporate the latest epidemiological data; 
review progress toward achieving national strategic plan goals; center 
the needs of populations disproportionately affected; address gaps 
identified in existing Strategic Plans; integrate the latest scientific 
advances; prioritize the most effective strategies for achieving 
national goals; and further emphasize the need to implement integrated 
syndemic approaches (https://www.hiv.gov/blog/defining-the-term-syndemic) that cut across each of the Strategic Plans and address 
common root causes of infectious diseases.
    OIDP, in collaboration with Federal partners, is updating the 
Strategic Plans at the same time because these conditions often 
disproportionately affect similar populations and may share common root 
causes. The Vaccine National Strategic Plan is included in this 
coordinated process to elevate the critical role vaccines can serve as 
a key intervention to prevent infectious disease, including STIs and 
viral hepatitis, and to disrupt syndemics. By updating the Strategic 
Plans at the same time, OIDP aims to identify, leverage, and maximize 
Federal and other resources to achieve health equity and reduce related 
health disparities.
    OIDP coordinates the development, implementation, and monitoring of 
the Strategic Plans in collaboration with Federal partners.
    Information Requested: Anyone can submit written responses to the 
questions of interest listed at the following website: https://app.smartsheetgov.com/b/form/68aa1bd9c54b42829f99e85cc4ab1e82.
    This feedback will inform the 2026-2030 Strategic Plans. Please 
note that responses have specified word limits. Please provide 
evidence-based justification where applicable. Professional societies, 
advocacy organizations, and other groups are encouraged to submit a 
single collective response that reflects the views of their membership.
    Responses to this RFI Notice are voluntary and may be made public 
by HHS. The submitted information will be reviewed by HHS staff and may 
be made available to the public, along with the submitting individual's 
name, email address, and demographic information consisting of the 
submitter's location, affiliated organization, role, and (if provided) 
title and nature of comments. Submitted information will not be 
considered confidential, so do not include proprietary, classified, 
confidential, personal, or other sensitive information in your 
response. This request is for information and planning purposes and 
should not be construed as a solicitation or as an obligation of the 
Federal Government or the HHS. No awards will be made based on 
responses to this RFI. The information submitted will be analyzed and 
may be used in reports or presentations. Those who respond are advised 
that the HHS is under no obligation to acknowledge receipt of your 
comments or provide feedback on your submission. The HHS and the 
government reserve the right to use any non-proprietary technical 
information in any future solicitation(s).
    Authority: 42 U.S.C. 202 and 42 U.S.C. 207.

B. Kaye Hayes,
Deputy Assistant Secretary for Infectious Disease; Director, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2024-22948 Filed 10-4-24; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>